|
|
|
Volumn 17, Issue 5 Suppl 5, 2003, Pages 52-55
|
|
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
7-ETHYL-10-HYDROXYCAMPTOTHECIN;
ANTINEOPLASTIC AGENT;
BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1;
BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1;
CAMPTOTHECIN;
DRUG DERIVATIVE;
GLUCURONOSYLTRANSFERASE;
IRINOTECAN;
ANIMAL;
DRUG EFFECT;
GENETIC POLYMORPHISM;
GENETICS;
HUMAN;
METABOLISM;
NEOPLASM;
REVIEW;
SYNDROME;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
GLUCURONOSYLTRANSFERASE;
HUMANS;
NEOPLASMS;
POLYMORPHISM, GENETIC;
SYNDROME;
|
|
EID: 0141560464
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (51)
|
|
References (16)
|
